These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 220442)

  • 1. [Liver diseases and endotoxin. I. Endotoxin in various liver diseases (author's transl)].
    Iwasaki M; Maruyama I; Ikeziri N; Abe M; Maeyama T; Nagata E; Abe H; Tanikawa K
    Nihon Shokakibyo Gakkai Zasshi; 1979 Feb; 76(2):239-48. PubMed ID: 220442
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endotoxin in severe liver diseases (author's transl)].
    Iwasaki M; Maruyama I; Ikeziri N; Abe M; Maeyama T; Nagata E; Abe H; Tanikawa K
    Nihon Shokakibyo Gakkai Zasshi; 1980 Mar; 77(3):386-94. PubMed ID: 6247524
    [No Abstract]   [Full Text] [Related]  

  • 3. [Endotoxin in liver cirrhosis. 1. Endotoxin in contained the ascitic fluid in liver cirrhosis].
    Tarao K; Endo O; Ikeuchi T; So K; Moroi T
    Nihon Shokakibyo Gakkai Zasshi; 1976 Nov; 73(11):1366-72. PubMed ID: 1034805
    [No Abstract]   [Full Text] [Related]  

  • 4. [Are endotoxins present in cirrhotic ascitic fluid? results of 110 limulus tests (author's transl)].
    Trinchet JC; Jupeau A; Hornstein M; Beaugrand M; Hecht Y; Ferrier JP
    Gastroenterol Clin Biol; 1981 Dec; 5(12):1103-7. PubMed ID: 7319206
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies of endotoxin in liver cirrhosis. 2. Clinical significance of the appearance of endotoxin during the cirrhotic change of the liver].
    Tarao K; So K; Moroi T; Ikeuchi T; Endo O
    Nihon Shokakibyo Gakkai Zasshi; 1977 Jun; 74(6):748-54. PubMed ID: 561244
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance of hemolysates test of ascitic fluid in late stage of schistosomiasis and cirrhosis of liver (author's transl)].
    Huang MX
    Zhonghua Nei Ke Za Zhi; 1980 May; 19(3):192-5. PubMed ID: 7227053
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of endotoxin in plasma and ascitic fluid of patients with cirrhosis: its clinical significance.
    Tarao K; So K; Moroi T; Ikeuchi T; Suyama T
    Gastroenterology; 1977 Sep; 73(3):539-42. PubMed ID: 892353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of immobilized histidine in assay for endotoxin in patients with liver disease.
    Shiomi S; Kuroki T; Ueda T; Takeda T; Nishiguchi S; Nakajima S; Kobayashi K; Yamagami S; Watanabe T; Minobe S
    J Gastroenterol; 1994 Dec; 29(6):751-5. PubMed ID: 7874271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of endotoxins in the blood serum and ascitic fluid in liver cirrhosis].
    Malinowski S
    Wiad Lek; 1980 Jul; 33(14):1125-7. PubMed ID: 7001756
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serum TBG value in chronic liver diseases and hepatoma with special referrence to microheterogeneity of TBG (author's transl)].
    Miyazaki J; Tanaka N; Iino S; Endo Y
    Horumon To Rinsho; 1982 Feb; 30(2):145-7. PubMed ID: 6177454
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical significance of hepatic tissue zinc contents in hepatocellular carcinoma and chronic liver diseases].
    Kameda Y
    Nihon Shokakibyo Gakkai Zasshi; 1983 Dec; 80(12):2556-63. PubMed ID: 6325778
    [No Abstract]   [Full Text] [Related]  

  • 12. [Changes of plasma amino acids levels in liver diseases (author's transl)].
    Morikawa T
    Nihon Shokakibyo Gakkai Zasshi; 1981 Nov; 78(11):2136-43. PubMed ID: 6276597
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunohistochemical examination of primary liver cancer (author's transl)].
    Nakanuma Y; Tanaka Y; Ohta G; Doishita K
    Nihon Shokakibyo Gakkai Zasshi; 1981 Aug; 78(8):1619-27. PubMed ID: 6172612
    [No Abstract]   [Full Text] [Related]  

  • 14. [The immunohistological study of alpha-fetoprotein on carcinoma of digestive organs (author's transl)].
    Shinzawa H; Kasajima T; Hirano Y; Ueno K; Imai Y; Ishikawa M
    Nihon Shokakibyo Gakkai Zasshi; 1980 Aug; 77(8):1250-6. PubMed ID: 6162045
    [No Abstract]   [Full Text] [Related]  

  • 15. [Progress of endotoxin and chronic liver disease].
    Wang L; Ren CS
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):251-3. PubMed ID: 12716536
    [No Abstract]   [Full Text] [Related]  

  • 16. Endotoxemia of cirrhosis: an observation not substantiated.
    Fulenwider JT; Sibley C; Stein SF; Evatt B; Nordlinger BM; Ivey GL
    Gastroenterology; 1980 May; 78(5 Pt 1):1001-4. PubMed ID: 6991352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early diagnosis of hepatocellular carcinoma (author's transl)].
    Yanagawa S; Suzuki M; Imaeda T; Doi H
    Rinsho Hoshasen; 1979 Jun; 24(6):701-2. PubMed ID: 88532
    [No Abstract]   [Full Text] [Related]  

  • 18. Endotoxins and renal failure in cirrhosis.
    Wilkinson SP; Williams R
    Lancet; 1980 Jun; 1(8183):1414. PubMed ID: 6104196
    [No Abstract]   [Full Text] [Related]  

  • 19. [Peritoneal fluid colony stimulating activity (CSA) release after Escherichia coli endotoxin infection (author's transl)].
    Nafziger J; Adolphe M; Guillosson JJ; Piette C; Piette M
    Ann Pharm Fr; 1981; 39(5):429-34. PubMed ID: 7034622
    [No Abstract]   [Full Text] [Related]  

  • 20. Endotoxemia in liver diseases: detection by a quantitative assay using chromogenic substrate with perchloric acid pretreatment.
    Yajima Y; Fukuda I; Otsuki M; Suzuki H; Ota S; Ishii M; Mori K; Goto Y
    Tohoku J Exp Med; 1985 Dec; 147(4):411-9. PubMed ID: 3008375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.